PMN

ProMIS Neurosciences Inc. Common Shares (ON)
Data: 2026-02-02
$13.435
Price
-5.12%
Change
$19.85
52W High
$0.2878
52W Low

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Quick Stats

58.1

AI Score

HOLD

0.22

Volume Ratio

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

PMN Stock Summary

Last updated Jan 27, 2026

PMN is currently trading at $13.435, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $0.2878 to $19.85.

Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 76.316, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.058, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PMN at 58.1/100 with a HOLD recommendation.

PMN (ProMIS Neurosciences Inc. Common Shares (ON)) Indicators

Last updated Jan 27, 2026

Indicator Value
RSI(14) 76.316
CMF (20) -0.058
ROC (10) 29.842
ADX (14) 46.842
Indicator Value
MACD (12,26,9) 0.743
AROONOSC (14) 100.0
WILLAMS %R (14) -21.774
MFI (14) 80.849
PMN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PMN Price vs Max Options Open Interest
PMN Max Change In Options Open Interest

PMN Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PMN Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PMN Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PMN Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

ProMIS Neurosciences Inc. Common Shares (ON) is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

PMN Moving Averages Analysis

PMN (ProMIS Neurosciences Inc. Common Shares (ON)) Simple Moving Averages

Moving Averages are last updated

Days MA

PMN Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 30.5 million
Earnings/Share ($) -23.77
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -27.2938
EPS Estimate Next Year ($) -10.958
WallStreet Target Price ($) 106.7435
Most Recent Quarter